Hi all
Having a look into 4DX and wondering what everyones thoughts are on the board's strategy moving forward. Is the general consensus that they are investing the $72M cash they had at Sep 21 4C in their current technology on a 'steady-as-we-go through clinical trial stage approach' or is the board fairly agile and also happy to look to acquire tech if its the right fit?
Just wanting to understand the boards strategy approach a little better.
Thanks all
Research, page-547
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
0.010(1.63%) |
Mkt cap ! $246.5M | |||
| Open | High | Low | Value | Volume |
| 61.0¢ | 63.0¢ | 60.0¢ | $302.9K | 497.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 29823 | 62.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.5¢ | 28527 | 3 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
62.5¢ |
Change
0.010 ( 1.63 %) |
||||
| Open | High | Low | Volume | ||
| 61.0¢ | 63.0¢ | 60.0¢ | 81319 | ||
| Last updated 15.59pm 16/05/2024 ? | |||||
| 4DX (ASX) Chart |